Antioxidant power of angiotensin-converting enzyme inhibitors in vitro

被引:39
作者
Benzie, IFF [1 ]
Tomlinson, B
机构
[1] Hong Kong Polytech Univ, Dept Nursing & Hlth Sci, Kowloon, Hong Kong
[2] Chinese Univ Hong Kong, Dept Clin Pharmacol, Hong Kong, Hong Kong
关键词
captopril; hypertension; ACE inhibitor; antioxidant; CHD; ROS; oxidative stress; FRAP assay;
D O I
10.1046/j.1365-2125.1998.00664.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims There is controversy regarding the potential antioxidant effect of captopril, therefore this study was performed to compare the in vitro antioxidant power of captopril with other angiotensin-converting enzyme (ACE) inhibitors. Methods Antioxidant power of captopril, enalapril, fosinopril, perindopril, quinapril and ramipril in aqueous solution was measured using the ferric reducing (antioxidant) Fewer (FRAP) assay; captopril was also measured in ethanolic solution. Results Only captopril showed significant antioxidant power, demonstrating a stoichiometric factor of 1.0 in this assay. Concentration-related antioxidant power was seen in both aqueous and ethanolic solutions. Conclusions Captopril shows antioxidant activity in vitro. This property could be relevant in vivo if captopril is concentrated in membranes, lipoproteins or at other important sites.
引用
收藏
页码:168 / 169
页数:2
相关论文
共 12 条
[1]   EVALUATION OF THE ABILITY OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR CAPTOPRIL TO SCAVENGE REACTIVE OXYGEN SPECIES [J].
ARUOMA, OI ;
AKANMU, D ;
CECCHINI, R ;
HALLIWELL, B .
CHEMICO-BIOLOGICAL INTERACTIONS, 1991, 77 (03) :303-314
[2]   DIRECT SCAVENGING OF FREE-RADICALS BY CAPTOPRIL, AN ANGIOTENSIN CONVERTING ENZYME-INHIBITOR [J].
BAGCHI, D ;
PRASAD, R ;
DAS, DK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 158 (01) :52-57
[3]   Lipid peroxidation: A review of causes, consequences, measurement and dietary influences [J].
Benzie, IFF .
INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 1996, 47 (03) :233-261
[4]   The ferric reducing ability of plasma (FRAP) as a measure of ''antioxidant power'': The FRAP assay [J].
Benzie, IFF ;
Strain, JJ .
ANALYTICAL BIOCHEMISTRY, 1996, 239 (01) :70-76
[5]  
Benzie IFF, 1997, BRIT J CLIN PHARMACO, V44, P209, DOI 10.1111/bcp.1997.44.2.209
[6]   CAPTOPRIL - A FREE-RADICAL SCAVENGER [J].
CHOPRA, M ;
SCOTT, N ;
MCMURRAY, J ;
MCLAY, J ;
BRIDGES, A ;
SMITH, WE ;
BELCH, JJF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (03) :396-399
[7]   CAPTOPRIL KINETICS [J].
DUCHIN, KL ;
SINGHVI, SM ;
WILLARD, DA ;
MIGDALOF, BH ;
MCKINSTRY, DN .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (04) :452-458
[8]   Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans [J].
Halliwell, B .
FREE RADICAL RESEARCH, 1996, 25 (01) :57-74
[9]   Captopril has no significant scavenging antioxidant activity in human plasma in vitro or in vivo [J].
Lapenna, D ;
DeGioia, S ;
Ciofani, G ;
Daniele, F ;
Cuccurullo, F .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (04) :451-456
[10]   PHARMACOKINETICS OF CAPTOPRIL AND ITS EFFECTS ON BLOOD-PRESSURE DURING ACUTE AND CHRONIC ADMINISTRATION AND IN RELATION TO FOOD-INTAKE [J].
OHMAN, KP ;
KAGEDAL, B ;
LARSSON, R ;
KARLBERG, BE .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 :S20-S24